Enrique Aranda

10PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersPacific Peoples youth and familyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 03, 2026
NR3C1, LAX1, and RCAN3 as Circulating Epigenetic Biomarkers for Prognosis and Chemotherapy Response Prediction in Metastatic Pancreatic Cancer.

Pablo Cano-Ramírez, Marta Toledano-Fonseca, María Teresa Cano-Osuna

|Dec 12, 2023
Anxiety, depression and quality of life: a longitudinal study involving cancer patient-caregiver dyads.

Francisco Garcia-Torres, Marcin J Jabłoński, Angel Gómez-Solís

|May 04, 2023
Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement.

Cristina Grávalos, Fernando Pereira, Ruth Vera

|Sep 08, 2022
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study.

Joana Vidal, Maria Concepción Fernández-Rodríguez, David Casadevall

|Jul 09, 2022
Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab.

M José Ortiz-Morales, Marta Toledano-Fonseca, Rafael Mena-Osuna

|Dec 23, 2021
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial.

Elena Élez, María Auxiliadora Gómez-España, Cristina Grávalos

Pageof 2

Frequent Collaborators

3 joint publications

Marta Toledano-Fonseca

3 joint publications

Antonio Rodríguez-Ariza

2 joint publications

Juan A Moriana

2 joint publications

María Teresa Cano-Osuna